Rki 057 〈2024-2026〉

Classification: RKI-057 is a synthetic small molecule identified as a potent and selective inhibitor of Receptor-Interacting Protein Kinase 1 (RIPK1) . It is primarily used in preclinical research for studying necroptosis —a regulated form of necrotic cell death.

RKI-057 functions by binding to the kinase domain of RIPK1, thereby blocking its enzymatic activity. RIPK1 is a key upstream mediator in the necroptotic pathway. When inhibited, the formation of the necroptosome complex (RIPK1-RIPK3-MLKL) is prevented, halting the downstream execution of necroptosis. This distinguishes it from apoptosis inhibitors, as it specifically targets programmed necrosis without directly affecting caspase-dependent pathways. Rki 057